What happened?
The nonprofit Blue Ridge Institute for Medical Research delivered a ranking based on the research funding given to the college by the National Institutes of Health, per the release.
The college received $3.2 million in NIH funding for FY 2023-24 and ranked No. 4 in Texas and No. 41 nationally in pharmacy schools, according to the release.
Additionally, the College of Pharmacy also advanced in the American Association of Colleges of Pharmacy’s 2024 research funding report. The pharmacy program moved from fifth to fourth place in Texas and climbed five spots nationally to No. 42, per UNT’s release. The association tracks total external research funding, which offers insight into how pharmacy schools are performing in securing competitive grants and expanding their research portfolios, according to the release.
The details
The college of pharmacy secured $6.8 million in total research funding, which is the highest in its history, and ranked second in Texas and 14th nationally for the percentage of faculty with federal funding, according to the release.
“These rankings are a testament to the strength, talent and innovation of our research faculty,” said Evan Robinson, dean of the College of Pharmacy. “Our faculty members not only advance impactful, federally funded research that improves patient care, but also mentor graduate and professional students eager to follow in their footsteps.”
What else?
The funding received from the NIH was used to advance discovery in vision science, neurodegenerative disease, ocular injury and repair, endocrinology and molecular mechanisms of disease.
“External grant funding is a metric for which we can be proud,” said Denise Inman, interim chair and professor of pharmaceutical sciences. “UNT Health ranks high in the state and in the nation. Behind those numbers are faculty, postdoctoral fellows and graduate students whose dedication to advancing knowledge — from disease processes to molecular design — makes this possible.”
